Antiviral drugs may be an essential component of the global polio eradication strategy, particularly for addressing challenges in the postpolio era.
Answers are grounded in this paper and cite their sources.
Animal data on picornavirus inhibitors support further polio antiviral exploration; human studies needed before any eradication role.
In 1988, the World Health Assembly launched the Global Polio Eradication Initiative, which aimed to use large-scale vaccination with the oral vaccine to eradicate polio worldwide by the year 2000. Although important progress has been made, polio remains endemic in several countries. Also, the current control measures will likely be inadequate to deal with problems that may arise in the postpolio era. A panel convoked by the National Research Council concluded that the use of antiviral drugs may be essential in the polio eradication strategy. We here report on a comparative study of the antipoliovirus activity of a selection of molecules that have previously been reported to be inhibitors of picornavirus replication and discuss their potential use, alone or in combination, for the treatment or prophylaxis of poliovirus infection.
No takes yet. Share an insight, caveat, or question.
Palma et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: